Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
about
Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19Applications of CYP450 testing in the clinical settingClopidogrel and proton pump inhibitors--where do we stand in 2012?CYP2C19 polymorphism influences Helicobacter pylori eradication25 Years of Proton Pump Inhibitors: A Comprehensive Review.Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Variation in gastric pH may determine kiwifruit's effect on functional GI disorder: an in vitro study.Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.Adverse effects of long-term proton pump inhibitor therapy.An update on the use of pantoprazole as a treatment for gastroesophageal reflux diseaseClinical application of pharmacogenomics.Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cellsEnantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography.Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease.Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.Clinical evidence of interaction between clopidogrel and proton pump inhibitorsMeta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumors.High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study.CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteersInfluence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Pharmacokinetics and pharmacodynamics of the proton pump inhibitors.Development of a novel, fully-automated genotyping system: principle and applications.Gastroesophageal reflux in critically ill children: a review.How May Proton Pump Inhibitors Impair Cardiovascular Health?Population-based mechanistic prediction of oral drug absorptionRecent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazoleThe pharmacology of esomeprazole and its role in gastric acid related diseases.Rhabdomyolysis associated with single-dose intravenous esomeprazole administration: A case report.Proton pump inhibitor and clopidogrel interaction: fact or fiction?CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.Gastrointestinal prophylaxis in neurocritical care.
P2860
Q24302187-C93737B7-AE56-4198-8350-2C691E44A91FQ24621760-B9C59F32-B3FB-44FC-840B-14CB0B50CB68Q26825728-1F449AC0-50AD-4BA4-95D6-AB73A20FA535Q27005916-B3320013-9555-413F-A410-54D8165C2420Q28070003-1F39D9D5-8810-4896-9B5A-C5610DA6868FQ30620638-C32DE3CC-C1C9-4B4E-A4CD-4F3EAF6D1E5AQ33570430-511F0089-AAC6-4AAE-A002-FB008719CA21Q33795077-102A5F56-B821-448B-8DD9-A66D25F0427DQ34079756-C04F761A-E93B-4D2A-A2FC-84FBEE2864CDQ34167899-8749D8FD-8192-406C-85C7-97471922D392Q34194502-2A1C84F8-F830-4918-A532-05AE2FE3C655Q34280685-8AA9D64E-EF15-4965-B0EF-64291D9B66ABQ34286825-E3E8E968-1E3D-489C-A9DA-274209DA1860Q34561771-4F3289B2-8CC9-4C35-8382-BAC6CD28AD02Q34822438-8B4EAEFF-ADD2-413A-878F-752F8C939634Q34873839-818D4A42-D93B-4D15-B366-09195B7ACF02Q34882331-73898D25-562C-4A59-AE85-927EC058ED81Q35007442-9F23F909-2103-4895-8A25-AFB22AA8F0EFQ35009679-EC3FA3FF-D890-41D6-8B63-A0028C7240B1Q35033722-C61E7353-02DD-4BDD-8D79-FADCDF1800AEQ35609726-F4B456BD-AB8D-435E-8587-EAD7E15B9E98Q35995525-57455086-96F4-4BF0-81A3-4B6487C2EB00Q36098476-FF43CD5D-992D-488F-B810-BA331D1122AEQ36164941-A9349136-832C-454E-9801-12A927337C7AQ36262935-FCDB1377-FD6D-4888-96B9-84FFAC4BAFC0Q36281192-83471BBD-406E-4548-B675-D503B884818FQ36542670-2FE40A85-E874-48FE-B0B2-77DF3857583FQ36608218-466578A9-B050-4C88-8CDD-055090B2EF0CQ36610419-22A86CC6-98C8-4617-913D-61DAF54AD5F9Q36892867-4DE3CCBA-6563-4CAB-873F-08D23D4F508BQ37214520-4210AC9E-48C1-443D-8DB7-BC4CFF457450Q37233904-51DEDF06-34E8-4583-B376-040852DC039AQ37260543-DAD8E3DD-45D4-41E5-A570-86271B74AE4EQ37552951-3F0E0C7B-83CA-4220-B842-DEC4D2FD2FC4Q37605518-40B07794-87EB-443A-B584-A55B46691B3CQ37630911-FC9CE8B3-7023-438F-8B32-32625D2BCFB9Q37646785-62EA95CE-8100-42E7-BD8F-DD9D0018FCBAQ37704535-C0D18A61-3CAB-4B28-BFA9-6AF8F1A7C004Q37834329-85F30B9D-0C12-4991-9AC0-A2622BFDCF22Q37900222-FB135AFA-A016-40A3-B112-3DD40B4DF71D
P2860
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@en
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@nl
type
label
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@en
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@nl
prefLabel
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@en
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@nl
P2860
P1476
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.
@en
P2093
Shaojun Shi
Ulrich Klotz
P2860
P2888
P304
P356
10.1007/S00228-008-0538-Y
P577
2008-08-05T00:00:00Z